Khosla Ventures

Tracked participation in 17 Atlas companies, with 14 explicitly attributed leads.

Firm website ↗

17portfolio companies

33round participations

14lead positions

$2.1Bled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jun 2026General IntuitionSeries A$320Mat $2.3B valuation Apr 2026FactorySeries C$150Mat $1.5B valuation Jan 2026WaabiSeries C$750M Dec 2025PolyAISeries D$86Mat $750M valuation Jul 2025Genesis AISeed (same $105M financing announcement republished)$105MJul 2025Genesis AISeed$105M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

GIGeneral Intuition$6BJun 2026 → Aug 20262 rounds1 led—

RRogo$2BApr 2025 → Apr 20264 rounds1 ledKeith Rabois

FFactory$1.5BApr 2026 → Apr 20261 round1 led—

WWaabi—Jun 2021 → Jan 20263 rounds3 led—

LLovable$6.6BDec 2025 → Dec 20251 roundParticipant—

PPolyAI$750MSep 2021 → Dec 20254 rounds2 led—

SASakana AI$2.7BJan 2024 → Nov 20253 rounds1 led—

FAField AIPhysical AIFieldAI is a physical-AI company building “one brain” autonomy software intended to help third-party robots (and…$2Bvaluation$587MraisedRecent roundsSeries A / Series A-1 (two consecutive rounds disclosed together) · Aug 2025$405M · led by Bezos Expeditions, Prysm +1earlier component of the two consecutive rounds (details limited)$91MSeries A-1 / initial priced venture round (amount disclosed as initial portion of 2025 total)$91M · Gates Frontier, SamsungField AI$2BAug 2025 → Aug 20251 roundParticipant—

MMoonvalleyWorld modelsMoonvalley is an AI research and creative tools company building professional generative video models trained on…$197MraisedRecent roundsSeries B (announced as additional $84M) · Jul 2025$84M · led by General CatalystAdditional cash (SEC Form D/A indicates first sale yet to occur and filing amendment; amount not stated in the SEC document text captured) · May 2025Venture funding (SEC filing; investor identities not disclosed) · Apr 2025$43MMoonvalley—Nov 2024 → Jul 20252 rounds1 ledVinod Khosla

GAGenesis AI—Jul 2025 → Jul 20252 rounds2 led—

AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10Abridge—Jun 2025 → Jun 20251 roundParticipant—

GGlean$7.2BJun 2025 → Jun 20251 roundParticipant—

RRegie.ai—Feb 2023 → Feb 20252 rounds1 led—

PIPhysical Intelligence$2.4BMar 2024 → Nov 20242 roundsParticipant—

NBNabla Bio—Dec 2021 → May 20242 rounds1 led—

RTRelation TherapeuticsScienceRelation Therapeutics is an AI-driven biopharmaceutical company building a biology-first, lab-and-computation “loop”…$116MraisedRecent roundsSeed (additional investment) · Dec 2025$26M · Data Collective Venture Capital (DCVC), DCVC +2Strategic collaboration (includes equity investment) · Dec 2025$55M · NovartisSeed (new seed financing) · Mar 2024$35M · led by Data Collective Venture Capital (DCVC)Relation Therapeutics—Mar 2024 → Mar 20241 roundParticipant—

RReplit$1.2BApr 2023 → Apr 20231 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Aug 24, 2026GIGeneral IntuitionFundraising (reported talks / new investment round)—$6BParticipant